(2S)-2-[[(2R)-2-[(2-chlorobenzoyl)amino]-3-methylbutanoyl]amino]-3-(4-fluorophenyl)propanoic acid
C21H22ClFN2O4 — CID 99781231
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-2-[[(2R)-2-[(2-chlorobenzoyl)amino]-3-methylbutanoyl]amino]-3-(4-fluorophenyl)propanoic acid
(2S)-2-[[(2R)-2-[(2-chlorobenzoyl)amino]-3-methylbutanoyl]amino]-3-(4-fluorophenyl)propanoic acid (PubChem CID 99781231) has the molecular formula C21H22ClFN2O4 and a molecular weight of 420.87 g/mol. Its IUPAC name is (2S)-2-[[(2R)-2-[(2-chlorobenzoyl)amino]-3-methylbutanoyl]amino]-3-(4-fluorophenyl)propanoic acid.
Molecular Properties
| Compound Name | (2S)-2-[[(2R)-2-[(2-chlorobenzoyl)amino]-3-methylbutanoyl]amino]-3-(4-fluorophenyl)propanoic acid |
|---|---|
| PubChem CID | 99781231 |
| Molecular Formula | C21H22ClFN2O4 |
| Molecular Weight | 420.87 g/mol |
| Exact Mass | 420.13 |
| IUPAC Name | (2S)-2-[[(2R)-2-[(2-chlorobenzoyl)amino]-3-methylbutanoyl]amino]-3-(4-fluorophenyl)propanoic acid |
| SMILES | CC(C)[C@@H](NC(=O)c1ccccc1Cl)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)O |
| InChI | InChI=1S/C21H22ClFN2O4/c1-12(2)18(25-19(26)15-5-3-4-6-16(15)22)20(27)24-17(21(28)29)11-13-7-9-14(23)10-8-13/h3-10,12,17-18H,11H2,1-2H3,(H,24,27)(H,25,26)(H,28,29)/t17-,18+/m0/s1 |
| InChIKey | OIUZQONJCQCSFJ-ZWKOTPCHSA-N |
| XLogP | 3.05 |
| TPSA | 95.50 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 420.87 |
| LogP ≤ 5 | 3.05 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 99781231 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.